No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
MAX MediaAlpha
- 17.850
- -0.410-2.25%
Close May 22 16:00 ET
- 17.410
- -0.440-2.46%
Post 18:04 ET
920.69MMarket Cap-26250P/E (TTM)
18.240High17.220Low873.07KVolume18.220Open18.260Pre Close15.46MTurnover2.29%Turnover RatioLossP/E (Static)51.58MShares25.78052wk High-48.24P/B680.29MFloat Cap7.62052wk Low--Dividend TTM38.11MShs Float70.333Historical High--Div YieldTTM5.59%Amplitude5.080Historical Low17.709Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
MediaAlpha Price Target Raised to $25.00/Share From $19.00 by Keefe, Bruyette & Woods
MediaAlpha Price Target Raised to $25.00/Share From $19.00 by Keefe, Bruyette & Woods
Express News | Keefe, Bruyette & Woods Reiterates Outperform on MediaAlpha, Raises Price Target to $25
MediaAlpha Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/15/2024 32.35% Keefe, Bruyette & Woods $19 → $25 Reiterates Outperform → Outperform 05/02/2024 58.81% C
KBW Issues a Buy Rating on MediaAlpha (MAX)
Express News | Mediaalpha Inc : KBW Raises Target Price to $25 From $19
Express News | NYSE Order Imbalance 73288.0 Shares on Buy Side
Comments
Investors express uncertainty about MediaAlpha's ability to meet growth expectations despite the stock's momentum and promising future revenue. The contrast of strong revenue outlook with the company's past performance may put pressure on the P/S ratio, signaling potential future revenue volatility.
Investors Still Aren't Entirely Convinced By MediaAlpha, Inc.'s (NYSE:MAX) Revenues Despite 30% Price Jump
TOP WATCH 2/24 + plays today 👍🏼 including AMAM explosion (3 alerts of it this week ⭐️)
AMAM 50%+ RUN 18% LHDX 17%
$Akebia Therapeutics(AKBA.US$ $AutoNation(AN.US$ $Cingulate(CING.US$ $Carvana(CVNA.US$ $Cyren(CYRN.US$ $Expedia(EXPE.US$ $Terran Orbital(LLAP.US$ $Intuitive Machines(LUNR.US$ $MediaAlpha(MAX.US$ $Ocean Biomedical(OCEA.US$ $SatixFy Communications(SATX.US$ $Starbucks(SBUX.US$ $Sellas Life Sciences(SLS.US$ $Vascular Biogenics(VBLT.US$
AMAM 50%+ RUN 18% LHDX 17%
$Akebia Therapeutics(AKBA.US$ $AutoNation(AN.US$ $Cingulate(CING.US$ $Carvana(CVNA.US$ $Cyren(CYRN.US$ $Expedia(EXPE.US$ $Terran Orbital(LLAP.US$ $Intuitive Machines(LUNR.US$ $MediaAlpha(MAX.US$ $Ocean Biomedical(OCEA.US$ $SatixFy Communications(SATX.US$ $Starbucks(SBUX.US$ $Sellas Life Sciences(SLS.US$ $Vascular Biogenics(VBLT.US$
3
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg